Prospect Capital Corporation vs Veeva Systems — how do they compare? Prospect Capital Corporation trades at $2.19 (market cap $1.13B), while Veeva Systems trades at $260.88 (market cap $42.88B). The key difference: Veeva Systems is far larger — about 37.9× Prospect Capital Corporation's market cap, and Prospect Capital Corporation pays a 19.09% dividend while Veeva Systems pays none. Which is the better fit depends on your goals.
| PSEC | VEEV | |
|---|---|---|
Market Cap | $1.13B | $42.88B |
Sector | Financials | Technology |
52-Week High | $3.05 | $306.22 |
52-Week Low | $2.11 | $151.43 |
Dividend Yield | 19.09% | — |
Enterprise Value | — | $35.79B |
Signals from Pluang's Aura AI — not financial advice
Prospect Capital (PSEC) trades at $2.19, down 1.79% recently, with a bearish technical signal and deep discount to book value (P/B 0.39). The company reported negative revenue and net income for 2025, though quarterly EPS has beaten estimates. It maintains a high dividend yield, paying $0.04 monthly, but faces net cash outflow and portfolio contraction concerns highlighted in recent news.
Outlook remains cautious due to financial deterioration and NAV erosion risks, offset by high yield and valuation discount. Analyst consensus is mixed with 25% buy ratings, reflecting divided opinion on recovery potential versus ongoing operational challenges.
No Aura AI signal available yet.
Trailing returns across standard periods
Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests primarily in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.
Read more on PSEC →Veeva Systems provides cloud software, data, and services for the life sciences industry. Its applications support functions across clinical research, regulatory operations, quality, safety, and commercial teams.
Read more on VEEV →